Cargando…
The German CaRe high registry for familial hypercholesterolemia – Sex differences, treatment strategies, and target value attainment
BACKGROUND AND AIMS: Familial hypercholesterolemia (FH) is among the most common genetic disorders in primary care. However, only 15% or less of patients are diagnosed, and few achieve the goals for low-density lipoprotein cholesterol (LDL-C). In this analysis of the German Cascade Screening and Reg...
Autores principales: | März, Winfried, Schmidt, Nina, an Haack, Ira, Dressel, Alexander, Grammer, Tanja B., Kleber, Marcus E., Baessler, Andrea, Beil, F. Ulrich, Gouni-Berthold, Ioanna, Julius, Ulrich, Kassner, Ursula, Katzmann, Julius L., Klose, Gerald, König, Christel, Koenig, Wolfgang, Koschker, Ann-Cathrin, Laufs, Ulrich, Merkel, Martin, Otte, Britta, Parhofer, Klaus G., Hengstenberg, Wibke, Schunkert, Heribert, Stach-Jablonski, Ksenija, Steinhagen-Thiessen, Elisabeth, Olivier, Christoph B., Hahmann, Harry, Krzossok, Stefan, Vogt, Anja, Müller-Wieland, Dirk, Schatz, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331285/ https://www.ncbi.nlm.nih.gov/pubmed/37434912 http://dx.doi.org/10.1016/j.athplu.2023.06.001 |
Ejemplares similares
-
PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
por: Katzmann, Julius L., et al.
Publicado: (2020) -
Why doesn’t high cholesterol hurt?
por: Katzmann, Julius L., et al.
Publicado: (2019) -
Phytosterols and Cardiovascular Risk Evaluated against the Background of Phytosterolemia Cases—A German Expert Panel Statement †
por: Windler, Eberhard, et al.
Publicado: (2023) -
Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
por: Katzmann, Julius L., et al.
Publicado: (2020) -
Gene Therapy Targeting PCSK9
por: Katzmann, Julius L., et al.
Publicado: (2022)